Tenofovir alafenamide versus tenofovir disoproxil fumarate, coformulated with elvitegravir, cobicistat, and emtricitabine, for initial treatment of HIV-1 infection: two randomised, double-blind, phase 3, non-inferiority trials

Sax, Paul E, Dr Prof ; Wohl, David, MD ; Yin, Michael T, Prof ; Post, Frank, MD ; DeJesus, Edwin, MD ; Saag, Michael, MD ; Pozniak, Anton, MD ; Thompson, Melanie, MD ; Podzamczer, Daniel, MD ; Molina, Jean Michel, Prof ; Oka, Shinichi, MD ; Koenig, Ellen, MD ; Trottier, Benoit, MD ; Andrade-Villanueva, Jaime, MD ; Crofoot, Gordon, MD ; Custodio, Joseph M, PharmD ; Plummer, Andrew, MS ; Zhong, Lijie, PhD ; Cao, Huyen, MD ; Martin, Hal, MD ; Callebaut, Christian, PhD ; Cheng, Andrew K, MD ; Fordyce, Marshall W, MD ; McCallister, Scott, MD

The Lancet (British edition), 2015-06, Vol.385 (9987), p.2606-2615 [Periódico revisado por pares]

England: Elsevier Ltd

Texto completo disponível